Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-01 Tanguler Tolga EVP, Chief Commercial Officer Grant or award · Stock Option (right to buy) +9,279 9,279
2024-03-01 Garg Pushkal CMO & EVP Dev & Med Affairs Grant or award +4,751 13,417
2024-03-01 Garg Pushkal CMO & EVP Dev & Med Affairs Grant or award · Stock Option (right to buy) +9,279 9,279
2024-03-01 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +7,741 27,219
2024-03-01 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award · Stock Option (right to buy) +15,118 15,118
2024-03-01 Greenstreet Yvonne Chief Executive Officer Grant or award +23,754 71,882
2024-03-01 Greenstreet Yvonne Chief Executive Officer Grant or award · Stock Option (right to buy) +46,394 46,394
2024-02-29 SHARP PHILLIP A Director Exercise or conversion 10b5-1 +30,000 $59.25 $1.8M 30,000
2024-02-29 SHARP PHILLIP A Director Sale 10b5-1 −13,005 $150.60 $2.0M 16,995
2024-02-29 SHARP PHILLIP A Director Sale 10b5-1 −13,557 $151.43 $2.1M 3,438
2024-02-29 SHARP PHILLIP A Director Sale 10b5-1 −915 $152.40 $139K 2,523
2024-02-29 SHARP PHILLIP A Director Sale 10b5-1 −1,906 $153.62 $293K 617
2024-02-29 SHARP PHILLIP A Director Sale 10b5-1 −101 $154.07 $16K 516
2024-02-29 SHARP PHILLIP A Director Sale 10b5-1 −516 $156.54 $81K 0
2024-02-29 SHARP PHILLIP A Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −30,000 0
2024-02-28 Tanguler Tolga EVP, Chief Commercial Officer Sale −216 $154.54 $33K 5,521
2024-02-28 Tanguler Tolga EVP, Chief Commercial Officer Sale −170 $155.45 $26K 5,351
2024-02-28 Tanguler Tolga EVP, Chief Commercial Officer Sale −100 $156.38 $16K 5,251
2024-02-28 Tanguler Tolga EVP, Chief Commercial Officer Sale −14 $157.30 $2K 5,237
2024-02-28 Tanguler Tolga EVP, Chief Commercial Officer Sale −1 $158.09 $158 5,236

Page 48 of 80 · 1,590 trades